US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Amplia Therapeutics Ltd.

0.0600

0.0000

Volume:- -

Turnover:- -

Market Cap:30.78M

PE:-4.50

High:0.0600

Open:0.0600

Low:0.0600

Close:0.0600

52wk High:0.2724

52wk Low:0.0287

Shares:513.07M

Float Shares:513.00M

Volume Ratio:0.18

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0133

EPS(LYR):-0.0133

ROE:-28.49%

ROA:-17.71%

PB:1.02

PE(LYR):-4.50

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Amplia Therapeutics Ltd.

Exchange:

OTCQB

Establishment Date:

2000

Employees:

- -

Office Location:

90 William Street,Level 5,Melbourne,Victoria,Australia

Website:

http://www.innateimmuno.com

Zip Code:

3000

Phone:

Fax:

61 3 9473 2555

Introduction:

Amplia Therapeutics Limited, a pharmaceutical company, focuses on development of focal adhesion kinase (FAK) inhibitors for cancer and fibrosis in Australia. The company's product pipeline includes AMP945, an inhibitor of FAK, for pancreatic cancer and idiopathic pulmonary fibrosis, as well as other solid tumors and fibrotic diseases indications, that has completed Phase I clinical trial; and AMP886 for acute myeloid leukemia (AML) and certain solid tumors.It has a collaboration agreement with the Garvan Institute of Media Research in Sydney. The company was formerly known as Innate Immunotherapeutics Limited and changed its name to Amplia Therapeutics Limited in September 2018. Amplia Therapeutics Limited was incorporated in 2000 and is headquartered in Melbourne, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/INNMF/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"INNMF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INNMF\",,,,,undefined,":{"symbol":"INNMF","market":"US","secType":"STK","nameCN":"Amplia Therapeutics Ltd.","latestPrice":0.06,"timestamp":1771880400000,"preClose":0.06,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":513000000,"shares":513071629,"eps":-0.013347,"marketStatus":"Pre-Mkt","change":0,"latestTime":"02-23 16:00:00 EST Delay","open":0.06,"high":0.06,"low":0.06,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.013347,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1771943400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"OTCQB","adjPreClose":0.06,"volumeRatio":0.1753155563429328},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INNMF\",,,,,undefined,":{"symbol":"INNMF","floatShares":513000000,"roa":"-17.71%","roe":"-28.49%","lyrEps":-0.013342,"volumeRatio":0.1753155563429328,"shares":513071629,"dividePrice":0,"high":0.06,"amplitude":0,"preClose":0.06,"low":0.06,"week52Low":0.0287,"pbRate":"1.02","psRate":"8.74","week52High":0.2724,"institutionHeld":0,"latestPrice":0.06,"eps":-0.013347,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.013347,"open":0.06,"prevYearClose":0.0789,"prevWeekClose":0.06,"prevMonthClose":0.1,"prevQuarterClose":0.0789,"fiveDayClose":0.0891,"twentyDayClose":0.1,"sixtyDayClose":0.0917},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INNMF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-04-18","symbol":"INNMF","defaultRemindTime":1713447000000,"type":"split","dateTimestamp":1713412800000,"forFactor":971896,"toFactor":1000000,"ratio":0.971896},{"market":"US","date":"2022-05-30","symbol":"INNMF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1653883200000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INNMF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INNMF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1753851600000},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":25021935,"yearFounded":2000,"address":"90 William Street,Level 5,Melbourne,Victoria,Australia","zipCode":"3000","officePhone":"61 3 9123 1140","officeFax":"61 3 9473 2555"},"stockCompanyDetail":{"websiteUrl":"http://www.innateimmuno.com","stockEarnings":[{"period":"1week","weight":0.2857},{"period":"1month","weight":0.2857},{"period":"3month","weight":-0.0856},{"period":"6month","weight":-0.302},{"period":"1year","weight":-0.7331},{"period":"ytd","weight":-0.3804}],"description":"Amplia Therapeutics Limited, a pharmaceutical company, focuses on development of focal adhesion kinase (FAK) inhibitors for cancer and  fibrosis in Australia. The company's product pipeline includes AMP945, an inhibitor of FAK, for pancreatic cancer and idiopathic pulmonary fibrosis, as well as other solid tumors and fibrotic diseases indications, that has completed Phase I clinical trial; and AMP886 for acute myeloid leukemia (AML) and certain solid tumors.It has a collaboration agreement with the Garvan Institute of Media Research in Sydney. The company was formerly known as Innate Immunotherapeutics Limited and changed its name to Amplia Therapeutics Limited in September 2018. Amplia Therapeutics Limited was incorporated in 2000 and is headquartered in Melbourne, Australia.","exchange":"OTCQB","name":"Amplia Therapeutics Ltd.","nameEN":"Amplia Therapeutics Ltd."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"INNMF\",market:\"US\",,,undefined,":null}}